Institution
Fujian Provincial Cancer Hospital
Recent research
- Health & MedicineOpen access
Abstract Topic Esophageal Cancer: Surgical Treatment of Esophageal Cancer – long term outcomes Background Esophageal cancer is one of the most common gastrointestinal malignancies worldwide. In China, most patients are diagnosed at intermediate and advanced stages, and the treatm...
- Health & MedicineOpen access
Abstract Topic Esophageal Cancer: Surgical Treatment of Esophageal Cancer Background Single-port thoracoscopic esophagectomy is an emerging minimally invasive technique that offers potential advantages in reducing surgical trauma and accelerating postoperative recovery. However,...
- Health & MedicineOpen access
Abstract Topic Esophageal Cancer: Surgical Treatment of Esophageal Cancer – technique Background Esophageal bypass surgery is a therapeutic approach for patients with unresectable esophageal cancer who cannot eat orally due to esophageal stricture. It is particularly indicated fo...
- Health & MedicineOpen access
To develop and externally validate a prediction framework integrating clinical factors, dose‒volume histogram (DVH) parameters, radiomics, dosiomics and deep - learning (DL) features for individualised radiation-induced hypothyroidism (RIHT) risk assessment. This retrospective mu...
- AI & ComputingOpen access
Computational Oncology of Chemotaxis-Driven Tumour–Immune Spatial Patterning and Stability
We develop a reaction–diffusion–chemotaxis model for spatial tumour–immune–chemokine dynamics that couples logistic tumour growth, immune-mediated killing, chemokine-dependent immune recruitment, chemotactic migration, and signal production. For the non-dimensional system, we est...
- Health & MedicineOpen access
CACA guidelines for the management of adult cancer pain
Abstract Cancer pain, one of the most prevalent and distressing symptoms in cancer patients, is closely associated with cancer diagnosis, therapeutic interventions, quality of life, and survival outcomes. Effective cancer pain management requires multidisciplinary collaborative a...
- Health & MedicineOpen access
Mefatinib, a novel second-generation epidermal growth factor (EGFR) tyrosine kinase inhibitor that has shown promising antitumor activity in targeting non-small cell lung cancer (NSCLC) with common and uncommon EGFR- activating mutations. In this phase III, randomized, double-bli...
- Health & MedicineOpen access
Perioperative Imatinib Treatment Continuation Patterns and Long-Term Outcomes in Locally Advanced Gastrointestinal Stromal Tumors After Neoadjuvant Therapy: An Exploratory Two-Center Retrospective Study
- Health & MedicineOpen access
Distant metastasis (DM) remains the leading cause of treatment failure in nasopharyngeal carcinoma (NPC), severely compromising long-term survival. Despite advances in screening and multimodal therapies, a considerable proportion of patients still develop DM after standard treatm...